https://www.neutherapeutics.com/source_blog daily 0.75 2021-06-27 https://www.neutherapeutics.com/source_blog/hernandez monthly 0.5 2021-06-27 https://www.neutherapeutics.com/source_blog/brinton monthly 0.5 2021-06-27 https://www.neutherapeutics.com/source_blog/blog-post-title-two-h69sb monthly 0.5 2020-05-20 https://www.neutherapeutics.com/source_blog/blog-post-title-three-acr5w monthly 0.5 2020-05-20 https://www.neutherapeutics.com/source_blog/blog-post-title-four-jslwk monthly 0.5 2020-05-20 https://www.neutherapeutics.com/investors daily 0.75 2021-06-26 https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1624592455761-T2QA77CWD71YUQVWLSA0/Allopregnanolone_formula_bleu.jpg Investors - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1624592312741-T837U5XY61MTIVV7SOFB/AdobeStock_192267315_Preview.jpeg Investors - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1624750636076-GEVKIB5N4E35H22P5FAB/colors.png Investors - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1624592285604-JWO5E5LAVDCO3WJKSONG/AdobeStock_300323877_Preview.jpeg Investors - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1624592253562-YS9PIH4JO9WCLC1HFQ7Y/AdobeStock_167247639_Preview.jpeg Investors - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1624631105829-D6FW1Q7F784L1BH1K8NU/Screen+Shot+2021-06-25+at+10.24.36+AM.png Investors - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1624592230332-ZKTEM83E64YLPVA2OY66/AdobeStock_33901847_Preview.jpeg Investors - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1624592411746-EMZ2DAZP2WL0H0U2YUCH/Screen+Shot+2021-06-08+at+1.06.02+PM.png Investors - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1624630883469-Q53AKGO9ZGERFTFI33JJ/istockphoto-1215467253-612x612.jpg Investors - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.neutherapeutics.com/home daily 1.0 2023-08-14 https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1629129744570-EDQHHBPZXP3UW7QFJA5U/neutherapeutics_alzheimer_stats_OL.png Home - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.neutherapeutics.com/pipeline/phytoserm daily 0.75 2021-08-27 https://www.neutherapeutics.com/news daily 0.75 2023-11-16 https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1624724511996-BBZNNTRO5S84HDDEE36E/nt_scientific_american.png News - Scientific American “Being female is a risk factor for Alzheimer’s. Why?” https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/a5b6986f-0598-42cd-a9ea-bb68c1dbf5d4/Screenshot+2023-10-20+at+1.46.16%E2%80%AFPM.png News - BizTuscon UArizona Startup NeuTherapeutics Wins $2.5M Grant https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1629186413557-98SF5AKA4NJDCJC5BZR0/nt_ua_news.png News - University of Arizona News “The UArizona drug development team recently launched the Phase 2b trial after securing more than $37 million in funding...” https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/a2784b05-4883-4b2d-a9fd-32e9865ba94c/NT+News+2+copy.jpg News - University of Arizona of A News Roberta Diaz Brinton, PhD, director of the Center for Innovation in Brain Science, has been named the Arizona Bioscience Researcher of the Year … https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1624724353143-Z20YLU2RZ15FSKINAVZ8/nt_alz_drug_discovery.png News - Alzheimer’s Drug Discovery Foundation “Dr. Brinton has successfully completed a phase 1b/2a human clinical trial. She is now preparing for a larger phase 2 clinical trial, which is also receiving funding from the ADDF...” https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/01182089-03d8-4922-bf47-e978c679f31e/Screenshot+2023-11-16+at+12.05.51%E2%80%AFPM.png News - Arizona Daily Star Tucson Tech: Startup developing supplement to ease menopausal hot flashes https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1624727253727-X57TOBMTMFVEF9MAVQYN/nt_alzheimers_net.png News - Alzheimers.net “Dr. Roberta Diaz Brinton has discovered that a neurosteroid, called allopregnanolone, helps to multiply and stimulate stem cells…” https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1624723078467-BRY0I3JJACJJT6FBCLYK/nt_atlantic.png News - The Atlantic “When Dr. Roberta Diaz Brinton first theorized that people with Alzheimer’s disease could grow back the brain cells they’d lost, almost nobody believed her.”… https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1624725012159-1CLX87UI4MJ683JXUYI1/nt_bis_tucon.png News - Biz Tucon “The National Institute on Aging awarded Brinton and her team at CIBS a $37.5 million clinical trial grant to research a potential regenerative therapy for Alzheimer’s…” https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1624725757858-NGD24C1GP7Q7CX21HQ3S/nt_nytimes.png News - The New York Times “Brinton is a brain scientist. Estrogen, particularly in its relationship to the health of the brain, is her obsession…” https://www.neutherapeutics.com/about daily 0.75 2022-09-10 https://www.neutherapeutics.com/pipeline/allopregnanolone daily 0.75 2023-08-03 https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1629138528051-AAWTLSRMKDWNI150BECO/neutherapeutics_allo_molecule.jpg Allopregnanolone - Phase 2b Clinical Trial Allopregnanolone has been approved for a Phase 2b clinical trial, REGEN-BRAIN© which is currently enrolling participants at sites across the country. https://www.neutherapeutics.com/contact daily 0.75 2021-08-16 https://www.neutherapeutics.com/old-team daily 0.75 2021-06-25 https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1624554903736-TXCTCNUFRILY4IP64YI1/gettyimages-1280305229-170667a.jpg Old team https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1624554903741-6JGWZM0X2IC3ZH7EOAZA/gettyimages-823303722-170667a.jpg Old team https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1624554903745-2DW9FSJ8UXWR5BL4WURF/gettyimages-1084664896-170667a.jpg Old team https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1624554903749-BGCVXC5CGNZTJHJM0MFY/gettyimages-1317784241-2048x2048.jpg Old team https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1624554903753-1R71636NSJ8ZQ00ZCJ39/gettyimages-1256711031-2048x2048.jpg Old team https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1624554903757-SNI0ZILK929I5GUX6JYB/gettyimages-1317784239-2048x2048.jpg Old team https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1624554903761-7Z5DN2YHJJA0HNNUQG1H/gettyimages-1280305229-170667a.jpg Old team https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1624554903764-FFHVPB4QESZTD6SY76K7/gettyimages-823303722-170667a.jpg Old team https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1624554903768-T1I719EFNCTJKNWIOS0M/gettyimages-1084664896-170667a.jpg Old team https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1624554903772-YALENAT1ZFT3PJ4WHIZJ/gettyimages-1317784241-2048x2048.jpg Old team https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1624554903776-KHIHLP77SY8PPC1O9CYE/gettyimages-1256711031-2048x2048.jpg Old team https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1624554903779-OQ8F4NCX2YCGL7M1YMIS/gettyimages-1317784239-2048x2048.jpg Old team https://www.neutherapeutics.com/articles/phytoserm daily 0.75 2021-06-28 https://www.neutherapeutics.com/publications/allopregnanolone daily 0.75 2023-08-03 https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1624737411504-8AKH46CJCK1RYI8RJ47E/alzheimers_association_logo.png Allopregnanolone - Exploratory imaging outcomes of a phase 1b/2a clinical trial of allopregnanolone as a regenerative therapeutic for Alzheimer's disease: Structural effects and functional connectivity outcomes https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1624736720353-859L5XYMN498NZQFVAZL/frontiers_logo.png Allopregnanolone - Neuroregenerative mechanisms of allopregnanolone in Alzheimer’s disease https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1624736619455-D53QD4CXA2V19HOHNJJ7/nih_logo.png Allopregnanolone - Neurosteroids as regenerative agents in the brain: therapeutic implications https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1624737411504-8AKH46CJCK1RYI8RJ47E/alzheimers_association_logo.png Allopregnanolone - Safety, tolerability, and pharmacokinetics of allopregnanolone as a regenerative therapeutic for Alzheimer's disease: A single and multiple ascending dose phase 1b/2a clinical trial https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1624736899433-0Y9RJDLY2AVWVJAX7C0O/plos_one_logo.png Allopregnanolone - Allopregnanolone Promotes Regeneration and Reduces β-Amyloid Burden in a Preclinical Model of Alzheimer's Disease https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1624736420171-X3DGWSZSVLTK5PJ5EDHS/science_direct_logo.png Allopregnanolone - Allopregnanolone as regenerative therapeutic for Alzheimer's disease: Translational development and clinical promise https://www.neutherapeutics.com/publications/phytoserm daily 0.75 2021-08-19 https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1624738973201-1B9URU1U92FSJJ1A5NFW/ios_press_logo.png PhytoSERM - Early Intervention with an Estrogen Receptor β-Selective Phytoestrogenic Formulation Prolongs Survival, Improves Spatial Recognition Memory, and Slows Progression of Amyloid Pathology in a Female Mouse Model of Alzheimer's Disease https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1624739322847-VTGRE0WK88B3VON0F2YH/menopause_llw_logo.jpeg PhytoSERM - Retrospective analysis of phytoSERM for management of menopause-associated vasomotor symptoms and cognitive decline: a pilot study on pharmacogenomic effects of mitochondrial haplogroup and APOE genotype on therapeutic efficacy https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1624741893870-ZKDK08A1VDNSPGTPINXM/ncbi_logo.png PhytoSERM - Safety and feasibility of estrogen receptor β targeted PhytoSERM formulation for menopausal symptoms: Phase 1b/2a randomized clinical trial https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1624739215163-X1VGWVLTUN0READAX32Q/ncbi_logo.png PhytoSERM - Estrogen receptor β-Selective Phytoestrogenic (Phyto-β-SERM) Formulation Prevents Physical and Neurological Changes in a Preclinical Model of Human Menopause https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1624738737104-F9T0I1UXK69GAQ93HGH9/acs_pubs_logo.png PhytoSERM - Structure-Based Virtual Screening for Plant-Based ERβ-Selective Ligands as Potential Preventative Therapy against Age-Related Neurodegenerative Diseases https://www.neutherapeutics.com/articles/allopregnanolone daily 0.75 2021-06-28 https://www.neutherapeutics.com/statement daily 0.75 2021-08-27 https://www.neutherapeutics.com/new-page-1 daily 0.75 2022-09-10 https://www.neutherapeutics.com/research-team daily 0.75 2021-07-14 https://www.neutherapeutics.com/research-team/hernandez monthly 0.5 2021-08-19 https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1625331808559-A64QYALSL1UUGBJ66S7C/team3.png Research Team - Gerson Hernandez, M.D., M.P.H, Chief Clinical Trials Officer - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.neutherapeutics.com/research-team/rodgers monthly 0.5 2021-08-19 https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1624815482951-VJMD3ZSLAIZ99FJTW3JN/team1.png Research Team - Dr. Kathy Rodgers, Ph.D., Chief Science Officer - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.neutherapeutics.com/research-team/lopez monthly 0.5 2021-08-19 https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1624832279364-X3Z8VRCSXPTFXDNNGXQL/team5.png Research Team - Claudia Lopez, B.S., Chief Compliance Officer - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.neutherapeutics.com/research-team/rinehart monthly 0.5 2021-08-19 https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1626828683780-5URWGDMD1XTFBGKN6TQH/team_rinehart.png Research Team - John Rinehart, MBA, MA, Chief Executive Officer - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.neutherapeutics.com/research-team/drew monthly 0.5 2021-08-19 https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1624832223071-GU26A3CNCM70A7NBSPJP/team4.png Research Team - Mark Drew, Ph.D., Chief Operations Officer - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.neutherapeutics.com/research-team/brinton monthly 0.5 2021-08-19 https://images.squarespace-cdn.com/content/v1/60d4bd8f75d9d45ff3fb3e49/1624761391151-W9164HFRKAHWNU6MV49J/team2.png Research Team - Dr. Roberta Diaz Brinton, Ph.D., Founder and President - Make it stand out Whatever it is, the way you tell your story online can make all the difference.